Ceftazidime 1gm Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided to you. It is essential to follow the instructions carefully. This medication can be administered in two ways: as an injection into a muscle or as an infusion into a vein over a period of time. In some cases, it may also be given as an injection directly into a vein.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the best way to store it.
Missing a Dose
If you miss a dose, contact your doctor to find out what steps to take next.
Lifestyle & Tips
- Complete the full course of treatment as prescribed, even if you start to feel better, to prevent the infection from returning and to reduce the risk of antibiotic resistance.
- Maintain good hydration unless otherwise instructed by your doctor.
- Report any new or worsening symptoms to your healthcare provider immediately.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Dark urine or yellow skin and eyes
Difficulty urinating or changes in urine output
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Redness or white patches in the mouth or throat
Vaginal itching or discharge
Severe diarrhea (C. diff-associated diarrhea, or CDAD), which may cause:
+ Stomach pain
+ Cramps
+ Loose, watery, or bloody stools
Neurological symptoms, such as:
+ Seizures
+ Confusion
+ Shakiness
+ Muscle twitching
+ Difficulty controlling body movements (more common in people with kidney problems)
If you experience any of these symptoms, contact your doctor immediately. Your doctor may need to adjust your dosage if you have kidney problems.
Common and Less Severe Side Effects
Most people do not experience severe side effects, and some may only have minor side effects. However, if you notice any of the following symptoms and they bother you or do not go away, contact your doctor:
Diarrhea
Upset stomach or vomiting
Stomach pain
* Irritation at the injection site
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Signs of allergic reaction: rash, itching, hives, swelling of face/lips/tongue, difficulty breathing.
- Severe or watery diarrhea, especially if it contains blood or mucus (may be a sign of *Clostridioides difficile* infection).
- New or worsening fever, chills, or sore throat (signs of superinfection or blood dyscrasias).
- Seizures or changes in mental status.
- Unusual bleeding or bruising.
- Yellowing of the skin or eyes (jaundice).
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking chloramphenicol.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing medications and health conditions.
Remember, do not start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
If you have diabetes and regularly test your urine for glucose, consult with your doctor to determine the most suitable testing method for you, as this medication may affect the accuracy of certain tests. Additionally, be sure to notify all your healthcare providers and laboratory personnel that you are taking this medication, as it may interfere with the results of some lab tests.
Do not take this medication for longer than prescribed, as this may increase the risk of a secondary infection. Older adults (65 years and older) should use this medication with caution, as they may be more susceptible to side effects.
If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
Overdose Information
Overdose Symptoms:
- Seizures
- Encephalopathy (confusion, altered consciousness)
- Asterixis (flapping tremor)
- Neuromuscular excitability
What to Do:
In case of suspected overdose, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222 in the US). Treatment is supportive. Hemodialysis may be useful in removing ceftazidime from the body.
Drug Interactions
Major Interactions
- Aminoglycosides (e.g., gentamicin, tobramycin): Increased risk of nephrotoxicity. Monitor renal function closely.
- Loop diuretics (e.g., furosemide): May increase ceftazidime serum concentrations. Monitor for increased adverse effects.
- Oral anticoagulants (e.g., warfarin): May enhance anticoagulant effect. Monitor INR/PT closely.
Moderate Interactions
- Probenecid: Decreases renal tubular secretion of ceftazidime, leading to increased and prolonged serum concentrations. Generally not co-administered unless therapeutic benefit outweighs risk.
- Vaccines (e.g., BCG, typhoid live): Antibiotics may reduce the therapeutic effect of live bacterial vaccines. Administer vaccines at least 24 hours after antibiotic discontinuation.
Minor Interactions
- Laboratory tests: May cause a false-positive direct Coombs' test. May cause false-positive urine glucose tests with copper-reduction methods (e.g., Benedict's solution, Fehling's solution).
Monitoring
Baseline Monitoring
Rationale: Ceftazidime is primarily renally eliminated; baseline assessment is crucial for dose adjustment, especially in patients with pre-existing renal impairment.
Timing: Prior to initiation of therapy
Rationale: Although hepatic metabolism is minimal, transient elevations have been reported. Baseline assessment helps identify pre-existing liver disease.
Timing: Prior to initiation of therapy
Rationale: To establish baseline values and monitor for potential hematologic adverse effects (e.g., eosinophilia, leukopenia, thrombocytopenia) during therapy.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Periodically, especially in patients with renal impairment, elderly, or those receiving concomitant nephrotoxic drugs
Target: Within normal limits or stable from baseline
Action Threshold: Significant increase in BUN/creatinine warrants dose adjustment or discontinuation.
Frequency: Periodically, if clinically indicated or with prolonged therapy
Target: Within normal limits or stable from baseline
Action Threshold: Significant elevation may warrant discontinuation.
Frequency: Periodically, especially with prolonged therapy
Target: Within normal limits
Action Threshold: Significant changes (e.g., leukopenia, thrombocytopenia) may warrant discontinuation.
Frequency: Daily throughout therapy and for several weeks post-therapy
Target: Absence of new infections
Action Threshold: Development of new infections requires appropriate diagnostic workup and treatment.
Symptom Monitoring
- Rash
- Hives
- Itching
- Difficulty breathing or swallowing
- Swelling of the face, throat, tongue, lips, or eyes
- Severe diarrhea (watery or bloody)
- Abdominal pain or cramps
- Fever
- Seizures
- Unusual bleeding or bruising
- Yellowing of skin or eyes (jaundice)
- Dark urine
Special Patient Groups
Pregnancy
Ceftazidime is classified as Pregnancy Category B. Animal reproduction studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed.
Trimester-Specific Risks:
Lactation
Ceftazidime is excreted in human milk in low concentrations. The amount ingested by an infant is generally considered low and unlikely to cause significant adverse effects. However, monitor breastfed infants for potential changes in bowel flora (e.g., diarrhea, candidiasis) or allergic reactions.
Pediatric Use
Dosing must be carefully calculated based on age, weight, and severity of infection. Neonates and infants have immature renal function, requiring specific dosing adjustments. Close monitoring for adverse effects is important.
Geriatric Use
Elderly patients are more likely to have decreased renal function, which may necessitate dose adjustment based on creatinine clearance. Monitor renal function closely to prevent accumulation and potential neurotoxicity (e.g., seizures).
Clinical Information
Clinical Pearls
- Ceftazidime is a key antibiotic for treating infections caused by *Pseudomonas aeruginosa*, including severe hospital-acquired infections and febrile neutropenia.
- It has good penetration into various body fluids and tissues, including cerebrospinal fluid when meninges are inflamed, making it suitable for meningitis.
- Unlike some other cephalosporins, ceftazidime has limited activity against Gram-positive bacteria and anaerobes, so it is often used in combination with other agents if broad-spectrum coverage is needed.
- Always adjust the dose in patients with renal impairment to prevent drug accumulation and potential neurotoxicity.
- Patients should be monitored for *Clostridioides difficile*-associated diarrhea (CDAD), which can occur with nearly all antibacterial agents, including ceftazidime.
Alternative Therapies
- Other anti-pseudomonal beta-lactams (e.g., Piperacillin/Tazobactam, Cefepime, Meropenem, Imipenem/Cilastatin, Doripenem)
- Aminoglycosides (e.g., Tobramycin, Amikacin, Gentamicin) - often used in combination with beta-lactams for severe *Pseudomonas* infections.
- Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) - for certain susceptible infections.
- Polymyxins (e.g., Colistin, Polymyxin B) - for highly resistant Gram-negative infections.